渤健公司股价在成交量放大的情况下出现下跌,最新跌幅达2.8%,报132.51美元。与此同时,美国FDA建议对使用渤健公司阿尔茨海默病药物的患者进行更严密的监测。
渤健公司股价在成交量放大的情况下出现下跌,最新跌幅达2.8%,报132.51美元。与此同时,美国FDA建议对使用渤健公司阿尔茨海默病药物的患者进行更严密的监测。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.